Patent Number: 8,815,837

Title: Respiratory disease treatment

Abstract: There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit.

Inventors: Finch; Harry (Buckinghamshire, GB), Fox; Craig (Buckinghamshire, GB), Sajad; Mohammed (Essex, GB), Bondil Van Niel; Monique (Essex, GB), Forrest; Andrew (Essex, GB)

Assignee: Pulmagen Therapeutics (Inflammation) Limited

International Classification: A01N 43/00 (20060101)

Expiration Date: 8/26/12018